Metagenomics In Healthcare Global Market Report 2025
상품코드:1855921
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
헬스케어용 군유전체학 시장 규모는 최근 급속히 확대하고 있습니다. 2024년 20억 7,000만 달러에서 2025년에는 24억 4,000만 달러로, CAGR 17.9%로 확대합니다. 실적 기간의 성장은 복잡한 메타유전체 데이터를 분석하기 위한 바이오인포매틱스 툴의 채택 증가, 신속하고 정확한 병원체 검출 방법에 대한 수요 증가, 신약 개발 및 바이오마커 식별을 위한 메타유전체 활용 확대에 기인합니다.
헬스케어 분야의 메타유전체 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다. 2029년에는 CAGR 17.6%로 46억 6,000만 달러로 성장할 것입니다. 예측 기간의 성장은 감염성 질환의 유병률 증가, 정밀의료에 대한 수요 증가, 메타유전체학을 이용한 항균제 내성 감시, 종양학 연구 및 진단에 대한 메타유전체학의 적용 확대, 미생물 기반 치료 및 중재에 대한 인식 증가에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 시퀀싱 플랫폼의 기술 발전, 바이오인포매틱스 파이프라인의 혁신, 단일 세포 메타유전체의 개발, 마이크로바이옴 치료제 연구개발, 데이터 분석에 인공지능의 통합 등이 있습니다.
헬스케어 메타유전체은 임상 샘플이나 환경 샘플에서 직접 얻은 유전물질을 분석하여 배양 없이 미생물 군집 전체를 연구하는 것입니다. 병원체 동정, 마이크로바이옴 구성 조사, 질병과 관련된 미생물 변화의 감지를 지원하여 정확한 진단, 맞춤 치료, 감염 관리 강화를 가능하게 합니다.
헬스케어 메타유전체의 주요 유형은 샘플 추출 키트와 메타유전체 키트가 있습니다. 샘플 추출 키트는 생물학적 샘플에서 데옥시리보핵산 또는 리보핵산을 효율적이고 안정적으로 분리하도록 설계된 상용 툴입니다. 차세대 시퀀싱, 중합효소 연쇄반응, 마이크로어레이 등의 기술을 채택하고, 샘플 채취, 데옥시리보핵산 추출, 라이브러리 준비, 시퀀싱 등의 워크플로우를 따릅니다. 감염병 진단, 유전체 역학, 맞춤의료, 마이크로바이옴 분석, 신약개발 등에 적용되어 병원, 진단연구소, 연구기관, 제약회사, 생명공학 기업 등의 최종사용자에게 서비스를 제공합니다.
2025년 봄, 미국의 갑작스러운 관세 인상과 그에 따른 무역 마찰은 헬스케어 분야, 특히 중요한 의료기기, 진단 기기, 의약품 공급에 심각한 영향을 미치고 있습니다. 병원과 의료 서비스 프로바이더들은 수입 수술기구, 영상 진단 장비, 주사기, 카테터 등 소모품의 비용 상승에 직면해 있습니다. 이러한 비용 상승은 의료 예산을 압박하고 있으며, 일부 의료기관은 장비 업그레이드를 늦추거나 환자에게 비용을 전가하고 있습니다. 또한 원자재 및 부품에 대한 관세는 필수적인 의약품 및 의료기기의 생산을 방해하여 공급망 병목현상을 유발하고 있습니다. 이에 대해 업계는 조달 전략을 다양화하고, 가능한 한 현지 생산을 촉진하고, 생명을 구하는 의료 제품에 대한 관세 면제를 옹호하고 있습니다.
이 보고서는 The Business Research Company의 헬스케어 메타유전체학 시장 통계를 담은 새로운 보고서 시리즈 중 하나로, 헬스케어 산업의 메타유전체학 세계 시장 규모, 지역별 점유율, 헬스케어 메타유전체학 시장 점유율, 헬스케어 메타유전체학 시장 점유율을 가진 경쟁사, 상세한 헬스케어 메타유전체 시장 부문, 시장 동향, 비즈니스 기회 등 경쟁사, 상세한 헬스케어 메타유전체 시장 부문, 시장 동향 및 비즈니스 기회 등 헬스케어 메타유전체 산업에서 성공하기 위해 필요한 데이터를 제공합니다. 이 헬스케어 메타유전체 시장 조사 보고서는 업계의 현재와 미래 시나리오를 상세하게 분석하여 필요한 모든 정보를 제공합니다.
감염성 질환 증가는 헬스케어 메타유전체 시장의 성장을 가속할 것으로 예측됩니다. 감염성 질환은 세균, 바이러스, 곰팡이, 기생충 등 유해한 미생물에 의해 발생하는 질병으로, 개인 간 직간접적으로 전파될 수 있습니다. 감염병의 유행 증가는 지역과 국가를 넘어 병원체의 확산을 가속화하는 여행 증가에 기인한 바가 큽니다. 헬스케어 분야의 메타유전체은 병원체를 신속하고 정확하게 식별할 수 있게 함으로써 이러한 질병을 퇴치하고 감염병 발생을 관리하는 데 있으며, 중요한 역할을 하고 있습니다. 복잡한 미생물 군집을 분석하여 진단의 불확실성을 줄이고, 환자 결과를 개선하며, 표적화된 치료 접근법을 촉진합니다. 예를 들어 2024년 2월 영국 보건안전국은 2023년 영국내 결핵 환자가 10.7% 증가하여 2022년 4,380명에서 4,850명으로 늘어났다고 보고했습니다. 그 결과, 감염성 질환의 확산은 헬스케어 메타유전체 시장의 확대를 촉진하고 있습니다.
헬스케어 메타유전체 시장의 주요 기업은 미생물 군집 프로파일링과 같은 혁신적인 솔루션을 개발하고 있습니다. 이 방법은 시퀀싱 및 생물정보학 툴을 사용하여 특정 시료에 포함된 미생물 집단을 종합적으로 분석하고, 그 구성, 다양성, 기능적 역할을 평가합니다. 예를 들어 2024년 8월 MGI테크는 인간 마이크로바이옴 메타유전체 시퀀싱 패키지를 출시했습니다. 이 패키지는 미생물 군집 프로파일링을 위한 자동화된 엔드투엔드 워크플로우를 제공하여 인간 마이크로바이옴의 다양성과 다양한 질병과의 연관성을 쉽게 분석할 수 있도록 합니다. 이 패키지는 수작업을 줄이고, 재현성을 높이며, 비용을 낮춰 대규모 임상 마이크로바이옴 연구를 보다 친숙하게 만듭니다. 연구자들은 보다 빠르고 정확한 미생물 식별과 적응 가능한 처리량을 통해 바이오마커 탐색을 지원하고, 번역 건강 연구를 진전시킬 수 있습니다.
2025년 5월, 인도에 본사를 둔 유전체 및 진단 기업 Mapmygenome India Limited는 마이크로바이옴 시퀀싱 및 분석 역량을 확대하기 위해 Microbiome Insights Inc. 이번 인수를 통해 맵마이지놈은 북미 시장에서의 입지를 강화하고 맞춤형 의료, 유전체학, 연구 서비스 제공을 강화하고자 합니다. 캐나다에 본사를 둔 Microbiome Insights Inc.는 헬스케어 분야의 메타유전체 분석 전문 기업입니다.
헬스케어 메타유전체 시장은 바이오인포매틱스 분석, 미생물 진단, 신약개발 지원 등의 서비스를 제공하는 사업체의 매출으로 구성됩니다. 시장 가치에는 서비스 프로바이더가 판매하거나 서비스 제공에 포함된 관련 상품의 가치도 포함됩니다. 헬스케어 메타유전체 시장에는 시퀀싱 플랫폼, 시약, 시약, 소모품, 바이오인포매틱스 툴의 판매도 포함됩니다. 이 시장에서의 가치는 '팩토리 게이트' 가치, 즉 다른 사업체(다운스트림 제조업체, 도매업체, 유통업체, 소매업체 등) 또는 직접 최종 고객에 의해 판매된 상품의 가치, 즉 상품의 제조자 또는 제작자가 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품을 만든 사람이 판매하는 관련 서비스도 포함됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 헬스케어용 군유전체학 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 헬스케어용 군유전체학 시장 : 성장률 분석
세계의 헬스케어용 군유전체학 시장 실적 : 규모와 성장, 2019-2024
세계의 헬스케어용 군유전체학 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 헬스케어용 군유전체학 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 헬스케어용 군유전체학 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
샘플 추출 키트
군유전체학 키트
세계의 헬스케어용 군유전체학 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
차세대 시퀸서
중합효소 연쇄 반응
마이크로어레이
세계의 헬스케어용 군유전체학 시장 : 워크플로우별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
샘플 수집
디옥시리보핵산 추출
라이브러리 조제
시퀀싱
세계의 헬스케어용 군유전체학 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
감염증 진단
게놈 역학
맞춤형 의료
마이크로바이옴 해석
Drug Discovery
세계의 헬스케어용 군유전체학 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
진단 연구소
연구기관
제약회사
바이오테크놀러지 기업
세계의 헬스케어용 군유전체학 시장 : 서브 세분화 샘플 추출 키트, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
디옥시리보핵산 추출 키트
리보핵산 추출 키트
단백질 추출 키트
세계의 헬스케어용 군유전체학 시장 : 서브 세분화 군유전체학 키트, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
라이브러리 조제 키트
시퀀스 키트
타겟 농축 키트
제7장 지역별·국가별 분석
세계의 헬스케어용 군유전체학 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 헬스케어용 군유전체학 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
헬스케어용 군유전체학 시장 : 경쟁 구도
헬스케어용 군유전체학 시장 : 기업 개요
F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
QIAGEN N.V.
BGI Genomics Co. Ltd.
Novogene Corporation
Oxford Nanopore Technologies Limited
Pacific Biosciences of California Inc.
MedGenome Labs Limited
Zymo Research Corporation
BaseClear B.V.
Psomagen Inc.
Karius Inc.
Microsynth AG
Macrogen Inc.
Norgen Biotek Corp.
Tiny Health Inc.
CosmosID Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
헬스케어용 군유전체학 시장 2029 : 새로운 기회를 제공하는 국가
헬스케어용 군유전체학 시장 2029 : 새로운 기회를 제공하는 부문
헬스케어용 군유전체학 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Metagenomics in healthcare is the analysis of genetic material obtained directly from clinical or environmental samples to study entire microbial communities without the need for culturing. It aids in identifying pathogens, examining microbiome composition, and detecting disease-associated microbial changes, enabling accurate diagnosis, personalized therapy, and enhanced infection management.
The main types of metagenomics in healthcare are sample extraction kits and metagenomics kits. Sample extraction kits are commercially available tools designed to efficiently and reliably isolate deoxyribonucleic acid or ribonucleic acid from biological samples. It employs technologies such as next-generation sequencing, polymerase chain reaction, and microarray, and follows workflows including sample collection, deoxyribonucleic acid extraction, library preparation, and sequencing. It is applied in infectious disease diagnosis, genomic epidemiology, personalized medicine, microbiome analysis, and drug discovery, serving end users including hospitals, diagnostic laboratories, research institutes, pharmaceutical companies, and biotechnology companies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The metagenomics in healthcare market research report is one of a series of new reports from The Business Research Company that provides metagenomics in healthcare market statistics, including metagenomics in the healthcare industry's global market size, regional shares, competitors with a metagenomics in healthcare market share, detailed metagenomics in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomics in healthcare industry. This metagenomics in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The metagenomics in healthcare market size has grown rapidly in recent years. It will grow from $2.07 billion in 2024 to $2.44 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to rising adoption of bioinformatics tools to analyze complex metagenomic data, increasing need for rapid and accurate pathogen detection methods, and growing use of metagenomics in drug discovery and biomarker identification.
The metagenomics in healthcare market size is expected to see rapid growth in the next few years. It will grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to increasing prevalence of infectious diseases, rising demand for precision medicine, greater focus on antimicrobial resistance surveillance using metagenomics, expanding applications of metagenomics in oncology research and diagnostics, and growing awareness of microbiome-based therapies and interventions. Major trends in the forecast period include technological advancements in sequencing platforms, innovations in bioinformatics pipelines, developments in single-cell metagenomics, research and development in microbiome therapeutics, and integration of artificial intelligence in data analysis.
The increasing prevalence of infectious diseases is expected to drive the growth of the metagenomics in healthcare market. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly between individuals. The rise in infectious disease prevalence is largely due to increased travel, which accelerates the spread of pathogens across regions and countries. Metagenomics in healthcare plays a crucial role in combating these diseases by enabling the rapid and accurate identification of pathogens, making it essential for managing infectious outbreaks. It reduces diagnostic uncertainty by analyzing complex microbial communities, improving patient outcomes, and facilitating targeted treatment approaches. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England rose by 10.7% in 2023, reaching 4,850 cases compared to 4,380 in 2022. Consequently, the growing prevalence of infectious diseases is driving the expansion of the metagenomics in healthcare market.
Leading companies in the metagenomics in healthcare market are developing innovative solutions, such as microbial community profiling. This method involves the comprehensive analysis of microbial populations in a specific sample, using sequencing and bioinformatics tools to assess their composition, diversity, and functional roles. For instance, in August 2024, MGI Tech Co. Ltd., a biotechnology company based in China, launched a Human Microbiome Metagenomics Sequencing Package. This package offers an automated, end-to-end workflow for microbial community profiling, making it easier to analyze human microbiome diversity and its link to various diseases. The package reduces manual labor, enhances reproducibility, and lowers costs, making large-scale and clinical microbiome research more accessible. Researchers benefit from faster and more precise microbial identification, as well as adaptable throughput, which aids in biomarker discovery and advances translational health research.
In May 2025, Mapmygenome India Limited, a genomics and diagnostics company based in India, acquired Microbiome Insights Inc. to expand its microbiome sequencing and analysis capabilities. With this acquisition, Mapmygenome aims to strengthen its presence in the North American market and enhance its offerings in personalized health, genomics, and research services. Microbiome Insights Inc., based in Canada, specializes in metagenomics for healthcare applications.
Major players in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., and Wobble Genomics Inc.
North America was the largest region in the metagenomics in healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in metagenomics in healthcare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the metagenomics in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The metagenomics in healthcare market consists of revenues earned by entities by providing services such as bioinformatics analysis, microbial diagnostics, and drug discovery support. The market value includes the value of related goods sold by the service provider or included within the service offering. The metagenomics in the healthcare market also includes sales of sequencing platforms, reagents, consumables, and bioinformatics tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Metagenomics In Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on metagenomics in healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for metagenomics in healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The metagenomics in healthcare market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Types: Sample Extraction Kits; Metagenomics Kits
2) By Technology: Next-Generation Sequencing; Polymerase Chain Reaction; Microarray
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Metagenomics In Healthcare Market Characteristics
3. Metagenomics In Healthcare Market Trends And Strategies
4. Metagenomics In Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Metagenomics In Healthcare Growth Analysis And Strategic Analysis Framework
5.1. Global Metagenomics In Healthcare PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Metagenomics In Healthcare Market Growth Rate Analysis
5.4. Global Metagenomics In Healthcare Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Metagenomics In Healthcare Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Metagenomics In Healthcare Total Addressable Market (TAM)
6. Metagenomics In Healthcare Market Segmentation
6.1. Global Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sample Extraction Kits
Metagenomics Kits
6.2. Global Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing
Polymerase Chain Reaction
Microarray
6.3. Global Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sample Collection
Deoxyribonucleic Acid Extraction
Library Preparation
Sequencing
6.4. Global Metagenomics In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Disease Diagnosis
Genomic Epidemiology
Personalized Medicine
Microbiome Analysis
Drug Discovery
6.5. Global Metagenomics In Healthcare Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Laboratories
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
6.6. Global Metagenomics In Healthcare Market, Sub-Segmentation Of Sample Extraction Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Deoxyribonucleic Acid Extraction Kits
Ribonucleic Acid Extraction Kits
Protein Extraction Kits
6.7. Global Metagenomics In Healthcare Market, Sub-Segmentation Of Metagenomics Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Library Preparation Kits
Sequencing Kits
Target Enrichment Kits
7. Metagenomics In Healthcare Market Regional And Country Analysis
7.1. Global Metagenomics In Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Metagenomics In Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Metagenomics In Healthcare Market
8.1. Asia-Pacific Metagenomics In Healthcare Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Metagenomics In Healthcare Market
9.1. China Metagenomics In Healthcare Market Overview
9.2. China Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Metagenomics In Healthcare Market
10.1. India Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Metagenomics In Healthcare Market
11.1. Japan Metagenomics In Healthcare Market Overview
11.2. Japan Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Metagenomics In Healthcare Market
12.1. Australia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Metagenomics In Healthcare Market
13.1. Indonesia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Metagenomics In Healthcare Market
14.1. South Korea Metagenomics In Healthcare Market Overview
14.2. South Korea Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Metagenomics In Healthcare Market
15.1. Western Europe Metagenomics In Healthcare Market Overview
15.2. Western Europe Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Metagenomics In Healthcare Market
16.1. UK Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Metagenomics In Healthcare Market
17.1. Germany Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Metagenomics In Healthcare Market
18.1. France Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Metagenomics In Healthcare Market
19.1. Italy Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Metagenomics In Healthcare Market
20.1. Spain Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Metagenomics In Healthcare Market
21.1. Eastern Europe Metagenomics In Healthcare Market Overview
21.2. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Metagenomics In Healthcare Market
22.1. Russia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Metagenomics In Healthcare Market
23.1. North America Metagenomics In Healthcare Market Overview
23.2. North America Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Metagenomics In Healthcare Market
24.1. USA Metagenomics In Healthcare Market Overview
24.2. USA Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Metagenomics In Healthcare Market
25.1. Canada Metagenomics In Healthcare Market Overview
25.2. Canada Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Metagenomics In Healthcare Market
26.1. South America Metagenomics In Healthcare Market Overview
26.2. South America Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Metagenomics In Healthcare Market
27.1. Brazil Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Metagenomics In Healthcare Market
28.1. Middle East Metagenomics In Healthcare Market Overview
28.2. Middle East Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Metagenomics In Healthcare Market
29.1. Africa Metagenomics In Healthcare Market Overview
29.2. Africa Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Metagenomics In Healthcare Market Competitive Landscape And Company Profiles
30.1. Metagenomics In Healthcare Market Competitive Landscape
30.2. Metagenomics In Healthcare Market Company Profiles
30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Metagenomics In Healthcare Market Other Major And Innovative Companies
31.1. QIAGEN N.V.
31.2. BGI Genomics Co. Ltd.
31.3. Novogene Corporation
31.4. Oxford Nanopore Technologies Limited
31.5. Pacific Biosciences of California Inc.
31.6. MedGenome Labs Limited
31.7. Zymo Research Corporation
31.8. BaseClear B.V.
31.9. Psomagen Inc.
31.10. Karius Inc.
31.11. Microsynth AG
31.12. Macrogen Inc.
31.13. Norgen Biotek Corp.
31.14. Tiny Health Inc.
31.15. CosmosID Inc.
32. Global Metagenomics In Healthcare Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Metagenomics In Healthcare Market
34. Recent Developments In The Metagenomics In Healthcare Market
35. Metagenomics In Healthcare Market High Potential Countries, Segments and Strategies
35.1 Metagenomics In Healthcare Market In 2029 - Countries Offering Most New Opportunities
35.2 Metagenomics In Healthcare Market In 2029 - Segments Offering Most New Opportunities
35.3 Metagenomics In Healthcare Market In 2029 - Growth Strategies
